Opioid Tolerance Treatment Market by Drug (Alpha2-Adrenoceptor Agonists, NMDA Antagonists, and Others), by Opioid Tolerance Type (Innate Tolerance and Acquired Tolerance), by Administration Route (Enteral and Parenteral), and by End-User (Hospitals & ASCs, Rehabilitation Centers, and Others)-Global Market Perspective, COVID-19 Business Impact, and Trends, 2020–2029
- TBI733140
- July 24, 2020
- Global
- 132 pages
- SAC Insights
Abstract
The report covers a forecast and an analysis of the global opioid tolerance treatment market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the global opioid tolerance treatment market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the global opioid tolerance treatment market on a global level.
In order to give the users of this report a comprehensive view of the global opioid tolerance treatment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the global opioid tolerance treatment market is divided based on drug, administration route, opioid tolerance type, end-user, and region. The regional segment includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.
Some major players operating in the global opioid tolerance treatment market are Pfizer, GlaxoSmithKline, Boehringer Ingelheim, Teva Pharmaceutical, Mylan, Otsuka Pharmaceutical, Johnson & Johnson, Aurobindo Pharma, Acorda Therapeutics, and Zydus Cadila.
This report segments the global opioid tolerance treatment market into:
Global Opioid Tolerance Treatment Market: Drug Analysis
NMDA Antagonists
Ketamine
Dextromethorphan
Others
Alpha2-Adrenoceptor Agonists
Clonidine
Tizanidine
Others
Others
Global Opioid Tolerance Treatment Market: Opioid Tolerance Type Analysis
Innate Tolerance
Acquired Tolerance
Global Opioid Tolerance Treatment Market: Administration Route Analysis
Enteral
Parenteral
Global Opioid Tolerance Treatment Market: End-User Analysis
Hospitals and ASCs
Rehabilitation Centers
Others (Homecare Settings and Research Institutes)
Global Opioid Tolerance Treatment Market: Regional Analysis
North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa
Table of Contents
Request Table Of Content
Click To Request Sample
Chapter 1. Introduction
1.1. Report description and scope
1.2. Research scope
1.3. Research methodology
1.3.1. Market research process
1.3.2. Market research methodology
Chapter 2. Executive Summary
2.1. Global Opioid Tolerance Treatment Market, 2017-2025 (USD Million)
2.2. Global Opioid Tolerance Treatment Market: Snapshot
| read more...
Related Reports
